Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma

International Journal of Cancer

Volumn 74, Issue 3, 1997, Pages 322-325

  Schmutzler, Rita K ^a   Bierhoff, Erhard ^a   Werkhausen, Thorsten ^a   Fimmers, Rolf ^a   Speiser, Paul ^b   Kubista, Ernst ^b   Krebs, Dieter ^a   Zeillinger, Robert ^b   Wiestler, Otmar D ^a   Von Deimling, Andreas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ANALYTIC METHOD; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CARCINOMA; CANCER GRADING; CELL DIFFERENTIATION; CHROMOSOME 13; GENE DELETION; GENE FREQUENCY; GENETIC MARKER; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TARGET CELL; TUMOR SUPPRESSOR GENE;

EID: 8544224972     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970620)74:3<322::AID-IJC15>3.0.CO;2-D     Document Type: Article

References (27)

1. ANDERSEN, T.I., GAUSTAD, A., OTTESTAD, L., FARRANTS, G.W., NESLAND, J.M., TVEIT, K.M. and BORRESEN, A.L., Genetic alterations of the tumour-suppressor-gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chrom. Cancer, 4, 113-21 (1992).
2. BENDER, B., WIESTLER, O.D. and VON DEIMLING, A., A device for processing large acrylamide gels. Biotechniques, 16, 204-206 (1994).
3. BLOOM, H.J. and RICHARDSON, W.W., Histological grading and prognosis in breast cancer. A study of 1049 cases of which 359 have been followed for 15 years. Brit. J. Cancer, 11, 359-377 (1957).
4. COLLINS, N., MCMANUS, R., WOOSTER, R., MANGION, J., SEAL, S., LAKHANI, S.R., ORMISTON, W., DALY, P.A., FORD, D., EASTON, D.F. and STRATTON, M.R., Consistent loss of the wild-type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene, 10, 1673-1675 (1995).
5. CROPP, C.S., Mutations in breast cancer. Cancer Lett., 90, 51-56 (1995).
6. GARCIA-FONCILLAS, J., ZORNOZA, G., MARTINEZ, M.J., GONZALES, M.S., HIDALGO, O.F., BRUGAROLAS, A. and MORENO-PALANQUES, R.F., Genetic instability, oncogene expression and/or DNA methylation is associated with inactivation of estrogen receptor (ER) in breast cancer. Proc. Amer. Ass. Cancer Res., 37, 578 (1996).
7. GUDAS, J.M., NGUYEN, H., LI, T. and COWAN, K.H., Hormone-dependent regulation of BRCA1 in human breast-cancer cells. Cancer Res., 55, 4561-4565 (1995).
8. LINDBLOM, A., ROTSTEIN, S., SKOOG, L., NORDENSKJOLD, M. and LARSSON, C., Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastasis. Cancer Res., 53, 3701-3711 (1993).
9. Louis, D.N., VON DEIMLING, A., SEIZINGER, B.R., (CA)n dinucleotide repeal assay for evaluating loss of allelic heterozygosity in small and archival human brain-tumor specimens. Amer. J. Pathol., 747, 777-782 (1992).
10. MARQUIS, S.T., RAJAN, J.V., WYNSHAW-BORIS, A., XU, J., YIN, G.Y., ABEL, K.J., WEBER, B.L. and CHODOSH, L.A., The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nature Genet., 11, 17-26 (1995).
11. MIKI, Y. and 43 OTHERS. A strong candidate for the breast- and ovarian-cancer susceptibility gene BRCA1. Science. 266, 66-71 (1994).
12. NAGAI, M.A., PACHECO, M.M., BRENTANI, M.M., MARQUES, L.A., BRENTANI, R.R., PONDER, B.A.J. and MILLIGAN, L.M., Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast-cancer patients. Brit. J. Cancer. 69, 754-758 (1994).
13. REMMELE, W., HILDEBRAND, U., HEINZ, H.A., KLEIN, P.J., VIERBUCHEN, M., BEHNKEN, L.J., HEICKE, B. and SCHEIDT, E., Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch. 409, 127-147 (1986).
14. SATO, T., FUTOSHI, A., SAKAMOTO, G., KASUMI, F. and NAKAMURA, Y., Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res., 51, 5794-5799 (1991).
15. SATO, T., TANIGAMI, A., YAMAKAWA, K., AKIYAMA, F., KASUMI, F., SAKAMOTO, G. and NAKAMURA, Y., Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50, 7184-9 (1990).
16. SCHMUTZLER, R.K., FIMMERS, R., BIERHOFF, E., LOHMAR, B., HOMANN, A., SPEISER, P., KUBISTA, E., JÄGER, K., KREBS, D., ZEILLINGER, R., WIESTLER, O.D. and VON DEIMLING, A., Association of allelic losses on human chromosomal arms 11q and 16q in sporadic breast cancer. Int. J. Cancer, 69, 307-11 (1996).
17. SKIRNISDOTTIR, S., EIRIKSDOTTIR, G., BALDURSSON, T., BARKARDOTTIR, R.B., EGILSSON, V. and INGVARSSON, S., High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: correlation with high PgR and low S phase. Int. J. Cancer, 64, 112-116 (1995).
18. SPIESSL, B., BEAHRS, O.B. and HERMANEK, P., UICC TNM Atlas. Illustrated guide to the TNM/pTNM classification of malignant tumors. Springer, Berlin (1990).
19. STANLEY, K., STJERNSWARD, J. and KOROLTCHOUK, V., Women and cancer. Wld Hlth Stat. Q., 40, 267-278 (1987).
20. TAKITA, K., SATO, T., MIYAGI, M., WATATANI, M., AKIYAMA, F., SAKAMOTO, G., KASUMI, F., ABE, R. and NAKAMURA, Y., Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res., 52, 3914-3917 (1992).
21. TAVASSOLI, F.A., Pathology of the breast, pp. 1-58, Appleton and Lange, Norwalk, Connecticut (1992).
22. VOGELSTEIN, B., FEARON, E.R., KERN, S.E., HAMILTON, S.R., PREISINGER, A.C., NAKAMURA, Y. and WHITE, R., Allelotype of colorectal carcinomas. Science. 244, 207-211 (1989).
23. VON DEIMLING, A., BENDER, B., Louis, D.N. and WIESTLER, O.D., A rapid and non-radioactive PCR-based assay for the detection of alletic loss in human ghomas. Neuropathol. appl. Neurol., 19, 524-529 (1993).
24. WATATANI, M., NAGAYAMA, K., IMANISHI, Y. KUROOKA, K., WADA, T., INUI, H., HIRAI, K., OZAKI, M. and YASUTOMI, M., Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy. Breast Cancer Res. Treat., 28, 231-9 (1993).
25. WICK, W., PETERSEN, T., SCHMUTZLER, R.K., WOLFARTH, B., LENARTZ, D., BIERHOFF, E., HÜMMERICH, J., MÜLLER, D., STANGL, A.P., SCHRAMM, J., WIESTLER, O.D., VON DEIMLING, A., Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to metastatic stage in breast cancer. Oncogene. 12, 973-978 (1996).
26. WOOSTER, R. and 40 OTHERS. Identification of the breast-cancer susceptibility gene BRCA2. Mature (Lond.), 378, 789-792 (1995).
27. WORLD HEALTH ORGANIZATION. Histological typing of breast tumors. 2nd ed. International classification of tumors 2. WHO. Geneva (1981).